Lignocaine is a class IB antiarrhythmic drug and is the first choice for VT. It is given intravenously in a dose of 1–3 mg/kg. For cardiac arrest, a 100 mg bolus is given, which may be repeated after ...

However, the efficacy of antiarrhythmic agents has not been rigorously evaluated in patients with ARVC, and limited data are available to support such use of these drugs. The Multidisciplinary ...